Drugs /

methionine c 11

Back to Drugs List

Overview

NCI Definition [1]:
A synthetic amino acid radiolabeled with carbon-11. Acting as a methyl donor, methionine C 11 is incorporated into macromolecules, where it serves as a positron emission tomography (PET) imaging agent for detecting tumors with high rates of protein synthesis.

Clinical Trials

View Clinical Trials for methionine c 11

Methionine c 11 has been investigated in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial investigating methionine c 11, 1 is phase 2 (1 open).

Rhabdomyosarcoma is the most common disease being investigated in methionine c 11 clinical trials [2].

Drug Details

Synonyms [2]:
c-11 met, methionine c11 (substance), c-11 methionine, methionine c^11^ (substance), methionine c11 (substance), methionine c11, methionine c11, methionine c^11^, 11c-methionine, carbon-11 methionine, methionine c11, 11c-met
NCIT ID [1]:
C1534
SNOMED ID [1]:
C-B103E

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.